While generally safe, the drug may cause mild side effects such as rash or irritation at the injection site. While Beyfortus is a powerful tool in preventing RSV in infants, parents and caregivers ...

Beyfortus, the new monoclonal antibody injection, similarly reduces the risk of RSV in infants for about five months—or one ...

suffering from respiratory syncytial virus (RSV) who is being ventilated in the ... which is given by intramuscular injection and is recommended by the CDC for all infants less than 8 months ...

Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus (RSV). It belongs to a group of medicines known as immunizing agents. This ...